Skip navigation

Global Disclosure Mandates • Data Sharing • Patient Privacy • Lay Summaries • Data and Document Anonymization

January 29-30, 2019
  • Philadelphia, PA

CBI’s Clinical Data Disclosure and Transparency is the most comprehensive meeting of its kind! Join your peers to discuss and disseminate aspects of required data disclosure in a time of industry reform. Spend your time with a laser focus on the implications of and approaches being taken for data sharing, ensuring compliance with regulations, navigating disclosure requirements and releasing patient-level data.

Progressive Insights and Industry Perspectives from Disclosure and Transparency Experts:

  • Navigate EU Clinical Trial Regulation and Its Impact
  • Assess the Impact that GDPR has on the Collection and Sharing of Clinical Trial Data
  • Examine the New September 2018 Draft Guidance from the FDA under Section 402(j) of the Public Health Services Act
  • Gain Insight from Different Perspectives on How Each Utilize Clinical Data and View Data Sharing
  • Explore Platforms Available for Data Sharing

Previous Attendee Acclaim:

Great speakers with real solutions.

Director, Clinical Innovation, Pfizer

A great forum for updates and trends on the evolving trial transparency landscape and compliance.

Director, Clinical Trial Disclsoure, Sanofi

This conference provided end to end information on key disclosure and transparency topics. Great way to
collaborate towards a common solution.

Director, Clinical Trial Disclosure and Transparency, Shire

Excellent Choice of speakers, spot on topics, very informative.

Manager, Clinical Trial Disclosure, Teva

Fantastic conference with very knowledgeable speakers on content. I strongly recommend this conference to new folks, as well as those already in the Pharma environment to attend so that they can have a better understanding of transparency.

Clinical Trial Transparency Coordinator, AstraZeneca

6th Annual Clinical Data Disclosure and Transparency

Global Disclosure Mandates • Data Sharing • Patient Privacy • Lay Summaries • Data and Document Anonymization

CBI’s Clinical Data Disclosure and Transparency is the most comprehensive meeting of its kind! Join your peers to discuss and disseminate aspects of required data disclosure in a time of industry reform. Spend your time with a laser focus on the implications of and approaches being taken for data sharing, ensuring compliance with regulations, navigating disclosure requirements and releasing patient-level data.

Progressive Insights and Industry Perspectives from Disclosure and Transparency Experts:

  • Navigate EU Clinical Trial Regulation and Its Impact
  • Assess the Impact that GDPR has on the Collection and Sharing of Clinical Trial Data
  • Examine the New September 2018 Draft Guidance from the FDA under Section 402(j) of the Public Health Services Act
  • Gain Insight from Different Perspectives on How Each Utilize Clinical Data and View Data Sharing
  • Explore Platforms Available for Data Sharing

Previous Attendee Acclaim:

Great speakers with real solutions.

Director, Clinical Innovation, Pfizer

A great forum for updates and trends on the evolving trial transparency landscape and compliance.

Director, Clinical Trial Disclsoure, Sanofi

This conference provided end to end information on key disclosure and transparency topics. Great way to
collaborate towards a common solution.

Director, Clinical Trial Disclosure and Transparency, Shire

Excellent Choice of speakers, spot on topics, very informative.

Manager, Clinical Trial Disclosure, Teva

Fantastic conference with very knowledgeable speakers on content. I strongly recommend this conference to new folks, as well as those already in the Pharma environment to attend so that they can have a better understanding of transparency.

Clinical Trial Transparency Coordinator, AstraZeneca